Clinical Trials Directory

Trials / Completed

CompletedNCT05642598

Pilot Study of a Smartphone-Based Vaping Cessation Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
Pivot Health Technologies Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

Prospective, open label, single center clinical study enrolling up to 100 participants to evaluate the effect of the Pivot vaping cessation program.

Detailed description

This is a prospective, open label, single center clinical study conducted with IRB approval enrolling up to 100 adult participants who report daily vaping. The study will be performed remotely on an ambulatory basis. Participants will be asked to set up and use the "Pivot for Vape" program. The program includes an app, moderated online community, and SMS-based coaching with a tobacco treatment specialist. The study duration is 52 weeks, with the estimated active time using the program of up to 6 months and the time thereafter as follow-up. Participants will receive online questionnaires at intervals throughout the study. Potential participants will complete an online screening form. Eligible participants will be called to confirm eligibility, discuss the study, and have their questions about the study answered. Interested eligible participants will complete the electronic informed consent form and baseline questionnaire prior to downloading the app on their smartphone. The investigators aim to assess the performance of the "Pivot for Vape" program, with a focus on assessing use and engagement, changes in attitudes towards quitting vaping and changes in vaping behavior over the course of the 1-year study, as well as participant feedback on the set-up, design, use experience, and impact of the program.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPivot for Vape"Pivot for Vape" vaping cessation smartphone app and program

Timeline

Start date
2023-02-07
Primary completion
2024-05-23
Completion
2024-05-23
First posted
2022-12-08
Last updated
2025-01-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05642598. Inclusion in this directory is not an endorsement.